Primary Neuroendocrine Neoplasia of the Liver

Daniel Kaemmerer; Almut Kunze; Franz C. Robiller; Merten Hommann; Martin Anlauf

doi:10.1097/RLU.0000000000003530

Primary Neuroendocrine Neoplasia of the Liver

Daniel Kaemmerer^*, Almut Kunze, Franz C. Robiller, Merten Hommann, Martin Anlauf

^*Corresponding author for this work

Clinic of Psychiatry and Psychotherapy

Abstract

The presence of primary neuroendocrine tumors in the liver is still a matter of controversy. We present a case of a somatostatin-receptor-positive mass of the liver in the 68Ga-DOTATOC PET/CT. No other primary tumor was found after conventional imaging, endoscopically, and after liver-segment resection. Immunohistochemically, a constellation of findings was found to be compatible with a primary neuroendocrine neoplasm of the liver.

Original language	English
Journal	Clinical Nuclear Medicine
Volume	46
Issue number	5
Pages (from-to)	409-410
Number of pages	2
ISSN	0363-9762
DOIs	https://doi.org/10.1097/RLU.0000000000003530
Publication status	Published - 01.05.2021

Research Areas and Centers

Academic Focus: Center for Brain, Behavior and Metabolism (CBBM)

DFG Research Classification Scheme

2.22-17 Endocrinology, Diabetology, Metabolism
2.22-14 Hematology, Oncology
2.23-06 Molecular and Cellular Neurology and Neuropathology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1097/RLU.0000000000003530

Cite this

@article{9592822a18c04847b23781accb24a369,

title = "Primary Neuroendocrine Neoplasia of the Liver",

abstract = "The presence of primary neuroendocrine tumors in the liver is still a matter of controversy. We present a case of a somatostatin-receptor-positive mass of the liver in the 68Ga-DOTATOC PET/CT. No other primary tumor was found after conventional imaging, endoscopically, and after liver-segment resection. Immunohistochemically, a constellation of findings was found to be compatible with a primary neuroendocrine neoplasm of the liver.",

author = "Daniel Kaemmerer and Almut Kunze and Robiller, \{Franz C.\} and Merten Hommann and Martin Anlauf",

year = "2021",

month = may,

day = "1",

doi = "10.1097/RLU.0000000000003530",

language = "English",

volume = "46",

pages = "409--410",

journal = "Clinical Nuclear Medicine",

issn = "0363-9762",

publisher = "Lippincott Williams and Wilkins",

number = "5",

}

TY - JOUR

T1 - Primary Neuroendocrine Neoplasia of the Liver

AU - Kaemmerer, Daniel

AU - Kunze, Almut

AU - Robiller, Franz C.

AU - Hommann, Merten

AU - Anlauf, Martin

PY - 2021/5/1

Y1 - 2021/5/1

N2 - The presence of primary neuroendocrine tumors in the liver is still a matter of controversy. We present a case of a somatostatin-receptor-positive mass of the liver in the 68Ga-DOTATOC PET/CT. No other primary tumor was found after conventional imaging, endoscopically, and after liver-segment resection. Immunohistochemically, a constellation of findings was found to be compatible with a primary neuroendocrine neoplasm of the liver.

AB - The presence of primary neuroendocrine tumors in the liver is still a matter of controversy. We present a case of a somatostatin-receptor-positive mass of the liver in the 68Ga-DOTATOC PET/CT. No other primary tumor was found after conventional imaging, endoscopically, and after liver-segment resection. Immunohistochemically, a constellation of findings was found to be compatible with a primary neuroendocrine neoplasm of the liver.

UR - https://www.scopus.com/pages/publications/85103801612

U2 - 10.1097/RLU.0000000000003530

DO - 10.1097/RLU.0000000000003530

M3 - Journal articles

C2 - 33630790

AN - SCOPUS:85103801612

SN - 0363-9762

VL - 46

SP - 409

EP - 410

JO - Clinical Nuclear Medicine

JF - Clinical Nuclear Medicine

IS - 5

ER -

Primary Neuroendocrine Neoplasia of the Liver

Abstract

Research Areas and Centers

DFG Research Classification Scheme

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this